Patent Assignment
Reel/Frame 061723/0829
Assignment of Assignor's Interest
Recorded: 2022-11-10
Pages: 2
Assignor
SCHOLZ, MATTHEW REIN
Executed: 2022-10-13
Assignee
OISIN BIOTECHNOLOGIES, INC.
701 FIFTH AVENUE, SUITE 4200, SEATTLE, WASHINGTON, 98104
Covered Properties
(4)
Fusogenic Lipid Nanoparticles and Methods for the Manufacture and Use Thereof for the Target Cell-Specific Production of a Therapeutic Protein and for the Treatment of a Disease, Condition, or Disorder Associated with a Target Cell
PCT:
PCT/US2019/028207 ↗
Fusogenic Lipid Nanoparticles for Target Cell-Specific Production of a Therapeutic Protein
Fusogenic Lipid Nanoparticles and Methods for the Manufacture and Use Thereof for the Target Cell-Specific Production of a Therapeutic Protein and for the Treatment of a Disease, Condition, or Disorder Associated with a Target Cell
Application:
62/659,676 →
Fusogenic Lipid Nanoparticles and Methods for the Manufacture and Use Thereof for the Target Cell-Specific Production of a Therapeutic Protein and for the Treatment of a Disease, Condition, or Disorder Associated with a Target Cell
Application:
62/821,084 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 27, 2018
From: SCHOLZ, MATTHEW REIN
To: OISIN BIOTECHNOLOGIES, INC.
Reel/Frame 047596/0680 →
Assignment of Assignor's Interest
Nov 10, 2022
From: HUDSON, GARY CHARLES
To: OISIN BIOTECHNOLOGIES, INC.
Reel/Frame 061723/0917 →
Assignment of Assignor's Interest
Nov 10, 2022
From: LEWIS, JOHN DAVID
To: OISIN BIOTECHNOLOGIES, INC.
Reel/Frame 061723/0954 →